Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials. (2019). SKIN The Journal of Cutaneous Medicine, 3, S38. https://doi.org/10.25251/skin.3.supp.38